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Tubular proteinuria defined by a study of Dent’s (CLCN5 The term “tubular proteinuria” has been applied to
mutation) and other tubular diseases. an electrophoretic pattern of urine proteins found in
Background. The term “tubular proteinuria” is often used patients with chronic proximal renal tubular diseaseinterchangeably with “low molecular weight proteinuria”
[1, 2]. This pattern of proteins represents increased excre-(LMWP), although the former implies a definite etiology. A
tion of several low molecular weight (LMW) proteins,specific quantitative definition of tubular proteinuria is needed,
and we address this by studying five different renal disorders. as well as albumin (molecular weight 65 kd) and
Methods. Tubular proteinuria was assessed by measuring b2-glycoprotein I (molecular weight 50 kd) [2–5]. These
urinary retinol-binding protein (RBP), b2-microglobulin (b2M), LMW proteins include b2-microglobulin (b2M; moleculara1-microglobulin (a1M), and albumin in 138 patients: 26 af- weight 12 kd) [3], a1-microglobulin (a1M; molecularfected males and 24 female carriers of the X-linked syndrome
weight 30 kd) [6], retinol-binding protein (RBP; molecu-“Dent’s disease,” 6 patients with other Fanconi syndromes, 17
with distal renal tubular acidosis (dRTA), 39 with glomerulone- lar weight 21 kd) [7], and urine protein 1 (Clara Cell
phritis (GN), and 26 with Chinese herbs nephropathy (CHN). Protein, molecular weight 20 kd) [8]. “Tubular protein-
Results. RBP was better than b2M or a1M in identifying the uria” is due to a failure of protein reabsorption by the
tubular proteinuria of Dent’s disease. Median urinary RBP
proximal tubule [2–4]. The terms tubular proteinurialevels in mg/mmol creatinine were: affected male Dent’s, 18.2,
and LMW proteinuria (LMWP) have usually been usedN 5 26; carrier female Dent’s, 0.30, N 5 24; dRTA, 0.027, N 5
17; GN, 0.077, N 5 39; and normal adults, 0.0079, N 5 61. interchangeably [9–11], but tubular proteinuria has no
Elevated urinary RBP (.0.017) and albumin , (10 3 RBP) 1 2 accepted quantitative definition. Here, LMWP is used
identified all patients with the LMWP of Dent’s disease and to mean excretion of one or more LMW proteins above
clearly distinguished their LMWP from that of dRTA and
the reference range, and tubular proteinuria is used toGN. This is a quantitative definition of tubular proteinuria.
mean LMWP in a patient known to have predominantlyConsistent with this definition, 80% of those patients with CHN
who had an elevated RBP had tubular proteinuria. Urinary proximal tubular disease.
RBP and albumin in carriers of Dent’s disease were strikingly Low molecular weight proteinuria is the most consis-
correlated over a 100-fold range (R 5 0.933). tent laboratory finding among male patients and female
Conclusion. The combination of elevated urinary RBP
carriers of the recently discovered X-linked tubular syn-(.0.017) and albumin , (10 3 RBP) 1 2 (mg protein/mmol
dromes caused by mutations of a renal chloride channel,creatinine) is a quantitative definition of tubular proteinuria.
Furthermore, our findings suggest that a shared defect in tubu- CLCN5 [12]. These familial tubular syndromes comprise
lar RBP and albumin reuptake causes this form of proteinuria. “Dent’s disease” [13, 14], “X-linked recessive nephroli-
thiasis (XRN) with renal failure” [15–17], “X-linked re-
cessive hypophosphatemic rickets” [18], “LMWP with
Key words: low molecular weight proteinuria, Dent’s disease, retinol
hypercalciuria and nephrocalcinosis” [19, 20], “Japanesebinding protein, albumin, urine proteins, proximal renal tubular dis-
ease. idiopathic LMWP” [20, 21], “familial idiopathic LMWP”
[22], isolated patients with LMWP [23, 24], and a large
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syndromes all have similar phenotypic features and share Fanconi syndrome [29, 30] and two males with Lowe’s
syndrome [31] with severe mental impairment, multiplethe same genetic etiology of CLCN5 mutations, they will
be referred to as Dent’s disease [24]. ocular defects causing blindness, and a renal generalized
aminoaciduria, phosphaturia, and glycosuria.Studies of individuals at risk of Dent’s disease require
screening of patients for tubular proteinuria, but this is Distal renal tubular acidosis. Urine samples were ob-
tained from 17 patients: six females with maturity onsetimprecise without a quantitative definition. Excretion of
a single LMW protein above the upper reference level immune-related disease (all with nephrocalcinosis), eight
patients with familial disease (7 males and 1 female,has generally been used to identify tubular proteinuria
in such families [12, 25]. all except one male had nephrocalcinosis), and three
patients with sporadic dRTA (2 males with nephrocal-Previous, more limited studies showed that female
carriers of Dent’s disease have a wide quantitative varia- cinosis, 1 female without). Full clinical details of the
immune-related cases, and all but one of the familialtion of LMW proteins in urine [27]. We have further
investigated these patients and affected males with cases, have been published [32]. Seven of the eight famil-
ial cases had autosomal-dominant disease and wereDent’s disease as a clinically homogeneous group for the
study of tubular proteinuria. Because Dent’s disease can members of three families with AE1 mutations [33, 34].
All dRTA cases were acidotic when first studied, exceptbe confused clinically with distal renal tubular acidosis
(dRTA) caused by the coexistence of medullary nephro- for the youngest familial patients, who had an AE1 muta-
tion and a urinary acidification defect, but no nephrocal-calcinosis and rickets/osteomalacia [12, 13, 25, 26], it is
important to know the prevalence of tubular proteinuria cinosis or systemic acidosis (incomplete dRTA syn-
drome).in dRTA. LMWP is common in glomerulonephritis (GN)
in both adults and children [8–10], but this form of pro- Glomerulonephritis. All 39 patients had renal biopsies
confirming glomerular disease. The histologic diagnosesteinuria ought to be distinguished qualitatively from tu-
were IgA disease (N 5 6); focal segmental glomerulo-bular proteinuria because the etiology of the LMWP is
sclerosis (6); membranous nephropathy (6); minimaldifferent [3].
change disease (7); membranoproliferative disease (4);We have developed a new quantitative definition of
renal amyloidosis (4); diabetic glomerular disease (4);tubular proteinuria based on the measurement of RBP
Wegener’s granulomatosis and systemic lupus erythema-and albumin in random urine collections. This definition
tosus (1 each). Twenty-three of these patients were re-is ideally suited for studies of families at risk of Dent’s
ported previously [11]. Patients with serum creatininedisease and may substantially improve the specificity of
levels of over 200 mmol/L, a level at which raised serumscreening for these mutations. It may also be widely
RBP is associated with elevated RBP excretion [35],applicable to other groups of patients with renal disease.
were excluded.
Unselected patients screened for low molecular weight
METHODS proteinuria. These comprised specimens of urine from
Local research ethical committee approval was ob- 82 patients submitted over a six-month period for detec-
tained for all studies not part of routine care. tion of LMWP. These patients were either males (N 5
43) at risk, by clinical criteria, of having Dent’s disease
Patient selection or females at risk of being carriers of Dent’s disease (N 5
Dent’s disease. Twenty-eight affected male patients 39). They were referred from eight different nephrology
with Dent’s disease were studied. Each of these patients centers and were unselected with respect to the quality
had clinical features of the disease, had other affected or quantity of any proteinuria.
family members, and had a documented CLCN5 muta- Chinese herbs nephropathy. We studied 26 female pa-
tion [16, 24]. These included two atypical male patients tients with renal failure, a history of intake of Chinese
with CLCN5 mutations and a very mild phenotype who herbal medicine to induce weight loss, and a renal biopsy
are described in detail elsewhere [15, 28]. Patients with consistent with CHN. These patients have been reported
a renal transplant or receiving dialysis treatment were in detail previously [36].
excluded. Twenty-four female carriers of Dent’s disease Normal individuals. Sixty-one adults (age 16.1 to 58
were obligate carriers on the basis of being either the years) without a history of personal or familial renal
daughter or the mother of an affected male. Mothers of disease consented to provide specimens.
affected males also had one other affected first-degree Urine specimens. We collected random urine speci-
relative. All carriers were shown to be heterozygous for mens into sodium azide, approximately 200 mg/L final
CLCN5 mutations [16, 24]. concentration. Patients either sent their specimens by
Renal Fanconi syndromes. These included four adults mail at ambient temperature, and these were frozen at
(3 males and 1 female) from previously described fami- 2808C within 24 hours of original collection, or speci-
mens were frozen within six hours of collection. We keptlies with autosomal dominant noncystinotic idiopathic
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Table 1. Low molecular weight protein and albumin excretion in urine, and serum creatinine concentrations in the subject groups:
Dent’s disease, Glomerulonephritis, distal RTA, Chinese herbs nephropathy, and normal adults
Protein
mg/mmol creatinine
Mean 6 sem Affected males with Carrier females of
Median (10–90th centiles) Dent’s disease Dent’s disease Glomerulonephritis
RBP 21.462.9 0.71 60.22 1.05 60.40
18.2 (7.8–42) 0.30 (0.13–3.1) 0.077 (0.009–3.0)
N 5 26 N 5 24 N 5 39
b2M 12.7561.3 1.58 61.19 0.54 60.19
11.6 (4.9–28) 0.23 (0.13–1.9) 0.050 (0.012–2.2)
N 5 30 N 5 24 N 5 39
a1M 32.265.0 2.75 60.63 4.02 60.82
23.3 (4.4–62) 1.80 (0.53–8.3) 2.30 (0.44–9.8)
N 5 32 N 5 23 N 5 39
Albumin 37.963.7 3.31 60.79 288 635
33.2 (14–64) 1.93 (0.47–7.0) 202 (92–710)
N 5 32 N 5 24 N 5 39
Serum creatinine lmol/L 192645 50.069.3 167 648
Mean 6 sem N 5 32 N 5 24 N 5 39
Patients “A1” and “A2” (Fig. 1) are omitted from this Table.
specimens for analysis of albumin, RBP, and a1M not Chicago, IL, USA) was used for the following: cumula-
longer than three months at 2808C and up to one week tive centile plots to calculate the 10th and 90th centiles of
at 2208C. About one quarter of the specimens for analy- protein measurements (Table 1) and Pearson correlation
ses of b2M were stored up to two years before assay. coefficients on logarithmically transformed protein mea-
Among 20 specimens with a wide range of initial b2M surements and sample confidence ellipses (95%). We
concentrations, b2M levels did not change significantly state the exact number of patients studied when, for
for up to two years of storage at 2808C. In contrast, technical reasons such as an insufficient specimen, not
storage of urine specimens for RBP analysis at 2808C all of the protein measurements could be made on a
for six months, but not two months, caused appreciable small number of patients.
loss. Aliquots for analysis were frozen and thawed once
only; all protein analyses were performed within four
RESULTShours of specimens being thawed.
Familial tubular syndromes and glomerulonephritis
Analytical methods
Initially, three groups of patients were studied and
Creatinine was measured using a Beckman “CX-7t” compared with normal individuals: males affected with
analyzer with a kinetic alkaline picrate method (Beck- Dent’s disease and other forms of the Fanconi syndrome,
man Instruments, High Wycombe, U.K.; protocol 443- female carriers of Dent’s disease, and patients with GN.
340). Albumin and a1M were measured by rate nephe- The excretion of the three LMW proteins, RBP, b2M,lometry on a Beckman “Array 360t” analyzer; RBP was
a1M, and albumin, is shown in Table 1 and Figure 1.assayed by a sensitive double-antibody enzyme-linked
The marked LMWP demonstrated for all three proteins,immunosorbent assay using a generally available urine
RBP, b2M, and a1M and the albuminuria of males af-RBP standard [37]. b2M was measured by fluoroimmu- fected by Dent’s disease were indistinguishable from thatnoassay on an Abbott “IMxt” analyzer (Abbott Diag-
of the six patients with other forms of the Fanconi syn-nostics, Maidenhead, UK). Measurements of albumin,
drome (4 patients with the idiopathic adult Fanconi syn-a1M, and b2M with these methods yield a level below
drome and 2 patients with Lowe syndrome; Fig. 1). Fur-the lower limit of detection in approximately 5, 3, and
thermore, these results show that discrimination between9% of normal individuals, respectively. For presentation
female carriers and normal individuals is best with aof results, these individuals were scored as having protein
measurement of RBP and that discrimination was in theconcentrations at the lower limit of detection; this was
order RBP . b2M . albumin . a1M. The range of these2, 4, and 0.05 mg/L, respectively. Urine specimens were
proteins excreted among these groups of patients wastested for hematuria using a routine “dipstick” method
approximately 105-, 104-, 103-, and 103-fold, respectively.(“Multistix”t; Bayer Diagnostics, Newbury, UK).
RBP is therefore the optimum protein for the detection
Presentation of the results of tubular proteinuria.
Excretion of all three LMW proteins as well as albu-All protein levels are expressed as mg protein/mmol
creatinine. SYSTAT version 7.0t software (SPSS Inc., min was abnormal in the affected males with Dent’s
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Table 1. Continued
Protein
mg/mmol creatinine
Mean 6 sem Chinese herbs
Median (10–90th centiles) Distal RTA nephropathy Normal adults
RBP 0.04860.018 2.5260.82 0.008560.00045
0.027 (0.005–0.1) 1.24 (0.003–9.5) 0.0079 (0.004–0.011)
N 5 17 N 5 26 N 5 61
b2M 0.5860.35 — 0.013860.0021
0.065 (0.02–2.4) 0.0094 (0.004–0.32)
N 5 16 N 5 36
a1M 2.0360.56 9.5562.94 0.67860.052
1.10 (0.2–7.0) 5.15 (0.47–17) 0.556 (0.29–1.3)
N 5 17 N 5 26 N 5 61
Albumin 18.267.1 10.361.6 0.59560.038
6.60 (0.5–42) 9.7 (0.3–20.5) 0.54 (0.28–0.96)
N 5 17 N 5 26 N 5 61
Serum creatinine lmol/L 12069.6 316643 82617
Mean 6 sem N 5 17 N 5 26
Patients “A1” and “A2” (Fig. 1) are omitted from this Table.
disease. However, for all three proteins, there was sub- Effect of hematuria on low molecular weight
stantial overlap between female carriers with Dent’s dis- protein excretion
ease and patients with GN; when a1M was measured, Hematuria is common among patients with nephroli-
many affected males and patients with GN had similar thiasis, which is a frequent feature of Dent’s disease. We
results (Fig. 1C). Unlike LMW proteins, measurement therefore used a model system to determine whether
of albumin gave good discrimination between female car- hematuria might cause apparent LMW protein excre-
riers of Dent’s disease and patients with GN. These find- tion. RBP and albumin were measured in normal urine
ings suggested that it is essential to employ measurements samples after the addition of small quantities of blood
of albumin as well as an LMW protein to discriminate (0.001 to 0.1% by volume). Apparently elevated excre-
the tubular proteinuria of patients with Dent’s disease. tion of RBP was found if as little as one part blood in
Measurements of the three LMW proteins RBP, b2M, 10,000 parts urine by volume were added; this corre-
and a1M are displayed against albumin excretion in the sponded to just detectable (“1”) hematuria on dipstick
bivariate graphs of Figure 2. Discrimination between testing of fresh urine without added preservative (Table
female carriers of Dent’s disease and normal individuals 2). Control experiments demonstrated that sodium azide
is best when RBP and albumin are measured, and there
at the concentration (200 mg/L) used for routine collec-
is a striking correlation between RBP and albumin excre-
tion of specimens of urine did not affect measurementstion in carrier females of Dent’s disease (correlation
of RBP or albumin but inhibited positive testing forcoefficient, R 5 0.933 and R2 5 0.871, N 5 24). To a
blood (results not shown). The addition of azide waslesser degree this is also true of b2M (R 5 0.698, R2 5 essential for specimen stability at ambient temperature.0.487, N 5 24) and a1M (R 5 0.719, R2 5 0.517, N 5
Hematuria may therefore confound detection of LMWP,23). Results of protein measurements in the two atypical
although, as anticipated, the ratio of albumin to RBP inpatients belonging to the large North American kindred
this model (Table 2) is quite different to that in patientswith XRN [27] are labeled “A1” and “A2” in Figure 1.
with tubular proteinuria.Because RBP was the best marker among the LMW
proteins, graphical results for this protein only are pre-
Quantitative definition of tubular proteinuria
sented further, although similar measurements were
Because males and carrier females with Dent’s diseasemade of both b2M and a1M (Table 1).
should be groups with qualitatively similar “tubular pro-
Distal renal tubular acidosis teinuria,” we explored combinations of RBP and albu-
min measurements to find a function that separates thePatients with autoimmune, familial, and sporadic dis-
LMWP of these patients from the LMWP of the othertal RTA frequently had elevations of RBP excretion (13
patients studied. All affected males and carrier femalesout of 17) and therefore LMWP, although the increases
had an albumin excretion , (10 3 RBP) 1 2 where thewere often small (Table 1 and Fig. 3). The degree of
units for albumin and RBP are mg/mmol creatinine. Thealbuminuria among these patients was highly variable,
line of this function is shown in Figure 4. Measurementsranging from normal to elevated approximately 30-fold
above the upper reference limit (Fig. 3). within the confidence ellipses for carriers and patients
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Fig. 1. Excretion of (A) retinol-binding protein, (B) b2-microglobulin, (C) a1-microglobulin, and (D) albumin in four groups of subjects: “Affected,”
affected males with Dent’s disease and autosomal dominant Fanconi (“F”), and Lowe (“L”) syndromes; “Carrier,” female carriers of Dent’s
disease; “GN,” patients with glomerulonephritis; and “Normal” adults. Each point is the result for one patient, and the number of patients studied
is given in Table 1. Results for the two atypical Dent’s disease patients (discussed in the Results section) are labeled “A1” and “A2” in the
“affected” group. The median is shown by the line that bisects each rectangular box. This box identifies the middle 50th centile of results and the
“whiskers” extending from each box identify the lower and upper 25th centiles.
affected by Dent’s disease mutations, who have elevated mitted over a six-month period for detection of tubular
proteinuria as a screen for Dent’s disease. These 10 pa-RBP excretion, virtually all lie within the boundary de-
fined by this simple function. Results found in the hema- tients had relatively minor abnormalities of RBP (up to
3 times the upper limit of normal) or albumin excretionturia model (Table 2) correspond to the specific location
labeled in the bivariate graph (Fig. 4). (up to 15 times the upper limit of normal) or both (results
not shown). Such findings could not be interpreted byWe applied this definition to results from 10 patients
(4 males and 6 females) selected from 82 patients (43 reference to previous results on patients with tubular
proteinuria [28]. None of these 10 patients were subse-males and 39 females) whose urine specimens were sub-
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Fig. 2. (A) Retinol-binding protein, (B) b2-microglobulin, (C) a1-
microglobulin in the urine of the four groups of subjects in Figure 1.
Symbols are: (d) affected males with Dent’s disease and autosomal
dominant Fanconi (“F”) and Lowe syndromes (“L”); (r) carrier fe-
males of Dent’s disease; (m) patients with glomerulonephritis; and (h)
“normal” adults. Abbreviations to identify patients with glomerulone-
phritis are: IGA, IgA nephropathy; FS, focal segmental glomeruloscle-
rosis; MEM, membranous nephropathy; MIN, minimal change;
PRO, membranoproliferative glomerulonephritis; AMY, renal amyloid;
WEG, Wegener’s granulomatosis; SLE, systemic lupus erythematosus
and DM, diabetic nephropathy. Ellipses are 95% confidence boundaries.
quently found to have molecular genetic evidence of Twenty-four out of 26 patients with CHN had elevated
CLCN5 mutations, and none met our quantitative defi- RBP excretion, and in 79% of these (19 out of 24 pa-
nition of tubular proteinuria. Application of a quantita- tients), RBP and albumin excretion fell within the
tive definition in this group of patients with equivocal boundary defining tubular proteinuria (Fig. 5).
urine protein abnormalities therefore gave results consis-
tent with molecular genetic data.
DISCUSSION
Chinese herbs nephropathy Identification of tubular proteinuria is necessary to
diagnose a male patient affected by one of the X-linkedThis definition of tubular proteinuria was further ex-
renal syndromes referred to as Dent’s disease. LMWPamined in a group of patients with a tubulopathy that
is the most consistent laboratory finding among thisalmost certainly has a different etiology to Dent’s disease
group of patients, and a variety of LMW proteins, most[36]. To do this, we studied patients with CHN, as the
usually b2M, has been measured; substantial elevationstubulopathy of these patients has been attributed to in-
jury from toxic aristolochic acids in herbal preparations. of RBP and a1M have also been found [12, 17, 27]. b2M
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Fig. 3. Retinol-binding protein and albumin in the urine of patients Fig. 4. Plot of the function: albumin 5 (10 3 RBP) 1 2 (– – –). The
with (.) autoimmune, (m) familial, and (j) sporadic forms of dRTA; boundary of the upper limit of the adult normal excretion of retinol-
(r) carriers of CLCN5 mutations and (h) normal individuals. Ellipses binding protein (---) is superimposed on the 95% confidence ellipses
are 95% confidence boundaries. for affected male patients with Dent’s disease, female carriers of Dent’s
disease, patients with glomerulonephritis, and normal individuals (Fig.
2A shows identity of confidence ellipses).
Table 2. Apparent retinol-binding protein and albumin concentrations when blood is added to normal urine in vitro (protein concentrations
are expressed in mg/mmol creatinine)a
Ratio of blood to urine vol/vol
Control
without
1:105 1:104 1:103 addition of blood
RBP 0.008 0.009 0.020 0.007
(0.004–0.012) (0.005–0.013) (0.008–0.12) (0.004–0.012)
Albumin 0.58 1.63 12.3 0.48
(0.20–0.9) (1.2–1.95) (3.3–18.1) (0.22–0.8)
Semiquantitative blood estimation by dipstick testing 1 11 111 Negative
(11 to 111)
a Results are the mean of experiments with 5 different specimens of blood and urine (range in parentheses). Blood, 0.01 mL was added to 10 mL of fresh urine
(no added sodium azide), left for 30 minutes at room temperature, further diluted 10-fold and 100-fold in the same urine and frozen at -808C overnight. Assays
performed the next day were as described in the Methods section.
has been widely used but is known to be unstable in show that in carrier females, it may occasionally even
exceed that found in an affected male (b2M and a1M inacidic urine [7]. Previous reports and the results here
(Table 1, Figs. 1 and 2) suggest that any of the three Fig. 1 B, C) or at the other extreme may be normal (Fig.
1). Female patients with CLCN5 mutations and clinicalLMW proteins studied, except perhaps a1M (Fig. 1),
might be used to screen for LMWP in affected males, abnormalities of Dent’s disease have been reported [13,
17, 21, 25], and one of these female patients had a urinaryalthough, as discussed later in this article, the combina-
tion of RBP and albumin is optimal (Fig. 4). LMW pro- b2M excretion in the range of an affected male [21]. RBP
appears to be the most sensitive LMW protein for thetein findings in urine are indistinguishable among Dent’s
disease and patients with Lowe syndrome and Adult detection of female carriers, although even with mea-
surements of this protein, a small number of individualsIdiopathic Fanconi syndrome (Figs. 1 and 2), both well-
recognized causes of tubular proteinuria [2]. (3 out of 24) were misclassified as normal (Fig. 1A). The
cause of this variation is probably varying degrees ofLow molecular weight proteinuria in the female carri-
ers of Dent’s disease is less marked than in affected X-inactivation among the female patients [12, 38].
Levels of excretion of LMW proteins by patients withmales, and its detection is more difficult [12, 27]; occa-
sionally, it cannot be demonstrated in women proved to GN and female carriers of Dent’s disease were virtually
indistinguishable, although the degree of albuminuriacarry a CLCN5 mutation [13, 27]. However, our results
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lointerstitial” disease [39]. In the patients studied here,
with predominant proximal tubular disease, a1M gave
poor discrimination (Figs. 1C and 2C).
Thirteen out of 17 patients with dRTA showed slight
elevation of RBP excretion, and albuminuria was com-
mon but very variable (Fig. 3). However, of these 13
patients, only one patient had a combination of urinary
RBP and albumin, demonstrating tubular proteinuria by
the previously mentioned definition. In contrast to the
other 12 patients, this one patient had no evidence of
nephrocalcinosis when studied and, unlike the other
dRTA patients who were adults, this patient was 11 years
of age. This definition therefore provides results almost
fully consistent with the predominantly distal tubular
lesion of these patients [32]. The degree of either LMWP
or albuminuria was unrelated to the severity of nephro-
calcinosis or nephrolithiasis in these patients (results not
shown).
Fig. 5. Retinol-binding protein and albumin in the urine of patients Hematuria is, of course, common in patients with
with Chinese herbs nephropathy (CHN). Results for the CHN patients nephrolithiasis [40], and abnormal LMW protein levels(solid symbols, r) are superimposed on the 95% confidence ellipses
were found in the hematuria model used. The use offor male patients with Dent’s disease (s), female carriers of Dent’s
disease (e), patients with glomerulonephritis (n), and normal individu- sodium azide preservative inhibited the peroxidase activ-
als (h). The identity of the confidence ellipses is as for Figure 2A. ity of heme and made dipstick testing for hematuria
unreliable, so retrospective analysis of the patients stud-
ied could not be performed confidently by this method.
The in vitro model of hematuria suggests that hematuriawas quite different (Fig. 1D). This suggested to us that
the use of a combination of RBP and albumin as a bivari- may cause at least some of the LMWP found, but in
combination with albumin measurement, this is easilyate distribution (Fig. 2) would give the best discrimina-
tion. Such distributions have been used before [10, 11, distinguished from tubular proteinuria.
We found a high incidence of relatively minor abnor-39], but areas of the distribution have not been interpre-
ted as in Figure 4. The patients with tubular protein- malities of RBP or albumin excretion in urine samples
from patients at risk of Dent’s disease by clinical criteriauria—males with Dent’s disease, other patients with a
Fanconi syndrome—and carriers of Dent’s disease fall screened for LMWP prior to CLCN5 genotyping. The
quantitative definition of tubular proteinuria allowed rig-predominantly on the upper left of the graph. They have
relatively more urinary RBP than albumin. Patients on orous selection of those patients who had LMWP caused
by tubular disease from the others and also avoidedthe right hand of the graph range from those with sub-
stantial RBP and albumin excretion (many with forms possible interference from hematuria. This particularly
applies with the use of a sensitive RBP assay [37] andof GN) to those with almost pure albuminuria and hema-
turia. enhances the value of urine protein screening prior to
genotype determination.Using an iterative approach, we found that the combi-
nation of RBP excretion above the reference range Chinese herbs nephropathy is a rapidly progressive
interstitial fibrosis of which proximal tubular atrophy is(0.017 mg/mmol) and an albumin excretion less than
(10 3 RBP) 1 2, with units in mg/mmol creatinine, de- a major histologic feature [36]. CHN is probably caused
by ingestion of nephrotoxic aristolochic acids. It wasfines the boundary shown in Figure 4 and includes all
patients who are affected males (26 out of 26) and most important to apply the above quantitative definition to
a different group of patients from those in which it wascarrier females (21 out of 24) of Dent’s disease. This
function is simple enough to be applied readily to mea- originally derived (Dent’s disease patients), and CHN
patients were chosen for this task. The bivariate distribu-surements of RBP and albumin while providing good
discrimination. LMWP, defined as RBP excretion above tion of RBP and albumin and the superimposed function
we have used to define tubular proteinuria show thatthe reference range, is a necessary but not sufficient
condition for a patient to be defined as having tubular some 80% of patients with CHN who have elevated RBP
excretion do indeed have tubular proteinuria (Fig. 5).proteinuria. In a report of studies confined to patients
with primary GN, Hofmann et al “corrected” a1M mea- The five CHN patients without clear tubular proteinuria
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Norden et al: Tubular proteinuria and Dent’s disease248
2. van’t Hoff WG: Biology and genetics of inherited renal tubularby creatinine clearance (results not shown). Transient
disorders. Exp Nephrol 4:253–262, 1996microscopic hematuria occurs in a significant number of 3. Peterson PA, Evrin P-E, Bergga˚rd I: Differentiation of glomeru-
these patients and may confound the presence of tubular lar, tubular and normal proteinuria: Determinations of urinary
excretion of b2-microglobulin, albumin and total protein. J Clinproteinuria.
Invest 48:1189–1198, 1969Figure 2A demonstrates a striking correlation between 4. Maack T: Renal handling of proteins and polypeptides, in Hand-
excretion of RBP and albumin in the female carriers of book of Physiology, Renal Physiology (2nd ed), edited by Wind-
hager EE, New York, Oxford University Press, 1992, pp 2039–2082Dent’s disease. This clinical finding indicates that trans-
5. Norden AGW, Fulcher LM, Lapsley M, Flynn FV: Excretionport of RBP as well as albumin may, at least in part,
of b2-glycoprotein-I (apolipoprotein H) in renal tubular disease.share a common tubular reabsorption mechanism. A Clin Chem 37:74–77, 1991
6. Yu H, Yanagisawa Y, Forbes MA, Cooper EH, Crockson RA,common LMW protein pathway has also been suggested
MacLennan ICM: Alpha-1-microglobulin: An indicator proteinby in vitro findings of competitive binding of cultured
for renal tubular function. J Clin Pathol 36:253–259, 1983proximal cells to immobilized LMW proteins and albu- 7. Bernard AM, Moreau D, Lauwerys R: Comparison of retinol-
min [41]. However, other clinical and in vitro studies binding protein and b2-microglobulin determination in urine for
the early detection of tubular proteinuria. Clin Chim Acta 126:1–7,differ on whether LMW proteins and albumin compete
1982for reuptake [42, 43].
8. Bernard AM, Lauwerys RR, Noe¨l A, Vandeleene B, Lambert
CLC-5, the CLCN5 gene product that is absent or A: Urine protein 1: A sex-dependent marker of tubular or glomeru-
lar dysfunction. Clin Chem 35:2141–2142, 1989defective in Dent’s disease, is expressed at multiple sites
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10. Tomlinson PA, Dalton RN, Hartley B, Haycock GB, Chantleralbumin transporting receptor-mediated endocytic path- C: Low molecular weight protein excretion in glomerular disease:
way [44]. A comparative analysis. Paediatr Nephrol 11:285–290, 1997
11. Flynn FV, Lapsley M, Sansom PA, Cohen SL: Urinary excretionIt is thought that CLC-5 plays a role in endosomal
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